A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Laura Q. M. Chow
S. Gail Eckhardt
Cindy L. O’Bryant
Mary Kay Schultz
Mark Morrow
Stacy Grolnic
Michele Basche
Lia Gore
机构：
[1] University of Colorado Cancer Center,
[2] The Children’s Hospital,undefined
[3] University of Colorado Health Sciences Center at Fitzsimons,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Lonafarnib; SCH66336; Cisplatin; Gemcitabine; Farnesyltransferase; Phase I; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 646
页数：15
相关论文
共 50 条
  • [1] A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
    Chow, Laura Q. M.
    Eckhardt, S. Gail
    O'Bryant, Cindy L.
    Schultz, Mary Kay
    Morrow, Mark
    Grolnic, Stacy
    Basche, Michele
    Gore, Lia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 631 - 646
  • [2] A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors
    Gore, L.
    Holden, S. N.
    Cohen, R. B.
    Morrow, M.
    Pierson, A. S.
    O'Bryant, C. L.
    Persky, M.
    Gustafson, D.
    Mikule, C.
    Zhang, S.
    Palmer, P. A.
    Eckhardt, S. G.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1709 - 1717
  • [3] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [4] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [5] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    Schultheis, B.
    Kummer, G.
    Zeth, M.
    Brendel, E.
    Xia, C.
    Kornacker, M.
    Strumberg, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 333 - 339
  • [6] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    B. Schultheis
    G. Kummer
    M. Zeth
    E. Brendel
    C. Xia
    M. Kornacker
    D. Strumberg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 333 - 339
  • [7] A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors
    Fountzilas, Christos
    Adjei, Alex
    Opyrchal, Mateusz
    Evans, Rachel
    Ghasemi, Mohammad
    Attwood, Kristopher
    Groman, Adrienne
    Bshara, Wiam
    Goey, Andrew
    Wilton, John
    Ma, Wen Wee
    Iyer, Renuka
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (12) : 2063 - 2074
  • [8] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
  • [9] Phase I and pharmacokinetic study of the ovally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors
    Punt, CJA
    van Maanen, L
    Bol, CJJG
    Seifert, WF
    Wagener, DJT
    ANTI-CANCER DRUGS, 2001, 12 (03) : 193 - 197
  • [10] A Phase I Multicenter Study of Continuous Oral Administration of Lonafarnib (SCH 66336) and Intravenous Gemcitabine in Patients With Advanced Cancer
    Wong, Nan Soon
    Meadows, Kellen L.
    Rosen, Lee S.
    Adjei, Alex A.
    Kaufmann, Scott H.
    Morse, Michael A.
    Petros, William P.
    Zhu, Yali
    Statkevich, Paul
    Cutler, David L.
    Meyers, Michael L.
    Hurwitz, Herbert I.
    CANCER INVESTIGATION, 2011, 29 (09) : 617 - 625
12345